The Business Development Fundamentals in-person course provides a foundation of the key skills that are required to execute a licensing transaction. With a focus on the biopharma industry, the course is taught by senior executives who have personal experience and expertise in transactional and intellectual property law; business development – both sell and buy sides; finance; alliance management; negotiation, and university technology transfer.   Previous attendees include professionals from many international institutions. A sample of companies include: AlkermesNIHAmerican Society of HematologyGileadAmgenMerck National Taiwan UniversityBaylor College of MedicineNovartisBluebird BiosciencesQueensland University of TechnologyBiogenPfizerChinese University of Hong KongSanofiEli LillyTakedaEvotecUS Army Medical ResearchGenentech Who should take the course? Buy or sell-side business development or alliance management professionals with limited transactional experience Individuals interested in pursuing a career in business development, tech transfer, or alliance management Entrepreneurs Individuals who want to better understand the strategic role of business development in portfolio expansion or divestitures This three-day course will be held in person, June 13--15, 2025, in Boston, covering specific modules for each day. A case study will be distributed at the beginning of the course. Registration opens on January 27, 2025.Interested in only registering for an in-person course in Boston? For course-only registration instructions, email: courseshelp@bio.orgInstructors (click photos to view bios)

Advanced Business Development (ABD) is a long-running course focusing on all key aspects of transactions in the biopharma industry. This course is ideal for professionals ranging from those with limited experience (2–3 years) looking to advance their skills; and highly experienced dealmakers or executives looking to hone their skills and network with other dealmakers. Advanced Business Development incorporates lectures from experienced dealmakers, review of example models, dissection of actual deals, interaction with other participants, and live Q&A. Also, the course includes a mock negotiation scenario when each participant is a member of a deal team assigned to negotiate a transaction involving a drug in development with another team using an actual valuation and deal structuring model.This three-day course will be held in person, June 13--15, 2025, in Boston. Registration opens on January 27, 2025.Interested in only registering for an in-person course in Boston? For course-only registration instructions, email: courseshelp@bio.orgInstructors (click photos to view bios)